# Experimental Vaccine for Malaria in Adults in Mali

> **NCT00343005** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 54 (—)

## Conditions studied

- Plasmodium Falciparum Malaria

## Interventions

- **BIOLOGICAL:** AMA1-C1
- **DRUG:** AMA1-C1/alhydrogel Malaria Vaccine

## Key facts

- **NCT ID:** NCT00343005
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04-23
- **Primary completion:** —
- **Final completion:** 2008-01-22
- **Target enrollment:** 54 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00343005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00343005, "Experimental Vaccine for Malaria in Adults in Mali". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT00343005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*